Johannes L. Peterse

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer et al. · New England Journal of Medicine · 2002 · 6.5K citations · Full text

Medicine, Bioinformatics, Oncology +17

Neu-Protein Overexpression in Breast Cancer

Marc J. van de Vijver, Johannes L. Peterse, Wolter J. Mooi et al. · New England Journal of Medicine · 1988 · 867 citations

Medicine, Oncology, Pathology +15

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

Nina Bijker, Philip Meijnen, Johannes L. Peterse et al. · Journal of Clinical Oncology · 2006 · 663 citations

Medicine, Oncology, Radiation Oncology +16

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis

Patrick W.B. Derksen, Xiaoling Liu, Francis N. Saridin et al. · Cancer Cell · 2006 · 594 citations · Full text

Medicine, Cancer Biology, Oncology +16

Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials

Adri C. Voogd, Maja Nielsen, Johannes L. Peterse et al. · Journal of Clinical Oncology · 2001 · 570 citations

Medicine, Oncology, Surgery +14